Correction: host genetic factors and vaccine-induced immunity to hepatitis B virus infection.

Correction: host genetic factors and vaccine-induced immunity to hepatitis B virus infection.

[This corrects the article on p. e1898 in vol. 3.].

Bibliographic Details
Main Authors:	Hennig, B, Fielding, K, Broxholme, J, Diatta, M, Mendy, M, Moore, C, Pollard, A, Rayco-Solon, P, Sirugo, G, , v, Waight, P, Whittle, H, Zaman, S, Hill, A, Hall, A
Format:	Journal article
Language:	English
Published:	Public Library of Science 2011

Similar Items

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
by: Hennig, B, et al.
Published: (2008)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
by: Hennig, B, et al.
Published: (2008)

Correction: Host Genetic Factors and Vaccine-Induced Immunity to Hepatitis B Virus Infection.
by: Branwen J. Hennig, et al.
Published: (2011-01-01)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection.
by: Branwen J Hennig, et al.
Published: (2008-03-01)

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis
by: Ryckman, K, et al.
Published: (2010)

Correction: Host Genetic Factors and Vaccine-Induced Immunity to HBV Infection: Haplotype Analysis.
by: Kelli K. Ryckman, et al.
Published: (2011-01-01)

Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis.
by: Kelli K Ryckman, et al.
Published: (2010-08-01)

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program
by: Peto, T, et al.
Published: (2014)

Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986–90) and in the nationwide immunisation program
by: Peto, TJ, et al.
Published: (2014)

Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose
by: Mendy, M, et al.
Published: (2013)

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
by: Cavenaugh, J, et al.
Published: (2011)

<it>FTO </it>gene variation and measures of body mass in an African population
by: Hattersley Andrew T, et al.
Published: (2009-03-01)

Therapeutic vaccination against hepatitis B virus using heterolgous prime boost strategy with DNA and modified vaccinia virus ankara vectors
by: McConkey, S, et al.
Published: (2003)

Mortality in HIV infection is independently predicted by host iron status and SLC11A1 and HP genotypes, with new evidence of a gene-nutrient interaction.
by: McDermid, J, et al.
Published: (2009)

Hepatitis B vaccination
by: Pollard, A
Published: (2007)

Hepatitis B vaccination.
by: Pollard, A
Published: (2007)

Hepatitis B vaccination
by: Pollard, A
Published: (2007)

Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.
by: James S Cavenaugh, et al.
Published: (2011-02-01)

Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study.
by: McDermid, J, et al.
Published: (2013)

Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa.
by: Mendy, M, et al.
Published: (2010)

Long-term protection against HBV chronic carriage of Gambian adolescents vaccinated in infancy and immune response in HBV booster trial in adolescence.
by: Marianne A B van der Sande, et al.
Published: (2007-08-01)

Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.
by: Moore, C, et al.
Published: (2012)

Characterizing vaccine responses using host genomic and transcriptomic analysis.
by: O'Connor, D, et al.
Published: (2013)

Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
by: Jobarteh, M, et al.
Published: (2010)

KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
by: Yindom, L, et al.
Published: (2017)

Correction: Host Genetic Factors and Vaccine-Induced Immunity to Hepatitis B Virus Infection
Published: (2011-01-01)

Addressing vaccine inequities among Ukrainian refugees
by: Hill, M, et al.
Published: (2022)

Emergence of vaccine-derived poliovirus in high-income settings in the absence of oral polio vaccine use
by: Hill, M, et al.
Published: (2022)

HPV vaccination of immunocompromised hosts
by: S.M. Garland, et al.
Published: (2017-12-01)

Hepatitis B vaccination among medical students
by: Vinodhkumaradithyaa A, et al.
Published: (2008-01-01)

Schistosoma mansoni infection alters the host pre-vaccination environment resulting in blunted Hepatitis B vaccination immune responses.
by: Roshell Muir, et al.
Published: (2023-07-01)

Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.
by: O'Connor, D, et al.
Published: (2014)

Host iron redistribution as a risk factor for incident tuberculosis in HIV infection: an 11-year retrospective cohort study
by: McDermid Joann M, et al.
Published: (2013-01-01)

Vaccination for hepatitis C - characterising the host immune response and its implications for a successful therapeutic vaccine
by: Halliday, J, et al.
Published: (2013)

CD4 intragenic SNPs associate with HIV-2 plasma viral load and CD4 count in a community-based study from Guinea-Bissau, West Africa.
by: Hennig, B, et al.
Published: (2011)

Single nucleotide polymorphisms in the toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine
by: Moore, C, et al.
Published: (2012)

Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.
by: Godkin, A, et al.
Published: (2005)

UK vaccination schedule: persistence of immunity to hepatitis B in children vaccinated after perinatal exposure.
by: Yates, T, et al.
Published: (2013)

Application of a novel, rapid, and sensitive oligonucleotide ligation assay for detection of cancer-predicting mutations in the precore and basal core promoter of hepatitis B virus.
by: Mendy, M, et al.
Published: (2008)

Association of low-density lipoprotein receptor polymorphisms and outcome of hepatitis C infection
by: Hennig, B, et al.
Published: (2007)